期刊文献+

理冲生髓饮对Fischer344大鼠卵巢肿瘤组织的抑瘤作用及对VEGF表达的影响 被引量:9

Anti-Tumor Effect of Lichong Shengsui Decoction on Ovarian Tumor Tissue and the Impact on VEGF Expression in Fischer344 Rats
暂未订购
导出
摘要 目的观察理冲生髓饮对大鼠卵巢肿瘤组织血管内皮生长因子(VEGF)表达的影响。方法采用二甲基苯蒽(DMBA)卵巢局部埋线法诱发大鼠卵巢肿瘤模型,检测理冲生髓饮对卵巢肿瘤的抑瘤率,通过免疫组化SABC法检测肿瘤组织VEGF的表达情况。结果理冲生髓饮对卵巢肿瘤组织有抑制作用,其抑瘤率与桂枝茯苓丸组比较,差异有统计学意义(P<0.01);同时能够明显地降低卵巢瘤细胞中VEGF基因蛋白的表达水平,与模型组和桂枝茯苓丸组比较,差异均有统计学意义(P<0.05或P<0.01)。结论中药复方理冲生髓饮对卵巢恶性肿瘤组织中VEGF基因蛋白的过度表达有调节作用。 Objective To observe the impacts of lichong shengsui decoction on vascular endothelial growth factor( VEGF) of ovarian tumor tissue in rats. Methods Adopt the local thread embedding method with DMBA in ovary to induce ovarian tumor model in rat. Detect anti - tumor rate of lichong shengsui decoction for ovarian tumor. Detect the expression of VEGF in tumor tissue with IHC SABC assay. Results Licong shengsui decoction inhibited ovarian tumor tissue and its anti - tumor rate was different significantly in statistics as compared with guizhi fuling pill( P 〈 0.01 ). Additionally, it reduced apparently the expression level of VEGF gene protein in ovarian tumor cell, indicating significant difference in statistics as compared with model group and guizhi fuling pill( P 〈 0.05 or P 〈 0.01 ). Conclusion Chinese herbal compound, lichong shengsui decoction adjusts the excessive expression of VEGF gene protein in ovarian cancer tissue.
出处 《世界中西医结合杂志》 2010年第11期939-941,共3页 World Journal of Integrated Traditional and Western Medicine
基金 哈尔滨市科学技术局攻关资助项目(No.2005AA9CS116-21)
关键词 卵巢肿瘤 理冲生髓饮 血管内皮生长因子 免疫组织化学 Ovarian tumor Lichong shengsui decoction Vascular endothelial growth factor (VEGF) Vascular dementia(VD) IHC
  • 相关文献

参考文献5

二级参考文献40

  • 1陈震宇,赵丽嫣.Bcl-2家族与卵巢上皮性肿瘤[J].中国妇产科临床杂志,2002,3(1):62-64. 被引量:1
  • 2韩凤娟,王艳红,隋丽华,王秀霞,刘娟.理冲生髓饮药物血清对卵巢癌细胞集落形成和Bcl-2蛋白表达的影响[J].中国中医药科技,2005,12(6):345-346. 被引量:6
  • 3寿成超.抗血管生成与肿瘤生物治疗[J].中国肿瘤生物治疗杂志,2006,13(6):401-403. 被引量:3
  • 4韩贻仁.分子细胞生物学[M].北京:科学出版社,2003.665.
  • 5Roy H,Bhardwaj S,Yla-Herttuala S.Biology of vascular endothelial growth factors[J].FEBS Letters,2006,580(12):2879-2887.
  • 6Xie K,Wei D,Shi Q,et al.Constitutive and inducible expression and regulation of vascular endothelial growth factor[J].Cytokine Growth Factor Rev,2004,15(5):297-324.
  • 7Zachary I,Gliki G.Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family[J].Cardiovasc Res,2001,49(3):568-581.
  • 8Ferrara N,Gerber HP,LeCouter J.The biology of VEGF and its receptors[J].Nat Med,2003,9(6):669-676.
  • 9Saharinen P,Tammela T,Karkkainen MJ,et al.Lymphatic vasculature:development,molecular regulation and role in tumor metastasis and inflammation[J].Trends Immunol,2004,25(7):387-395.
  • 10Ferrara N,Hillan KJ,Gerber HP,et al.Discovery and development of bevacizumab,an anti-VEGF antibody for treating cancer[J].Nat Rev Drug Discov,2004,3(5):391-400.

共引文献47

同被引文献121

引证文献9

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部